BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35811220)

  • 1. Survival benefit of pancreatic enzyme replacement therapy in patients undergoing treatment of pancreatic neuroendocrine tumours.
    Thompson O; Hall L; Roberts K; Bradley E; Powell-Brett S; Pande R; Shah T
    HPB (Oxford); 2022 Nov; 24(11):1921-1929. PubMed ID: 35811220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy.
    Roberts KJ; Schrem H; Hodson J; Angelico R; Dasari BVM; Coldham CA; Marudanayagam R; Sutcliffe RP; Muiesan P; Isaac J; Mirza DF
    HPB (Oxford); 2017 Oct; 19(10):859-867. PubMed ID: 28711377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational study.
    Lamarca A; McCallum L; Nuttall C; Barriuso J; Backen A; Frizziero M; Leon R; Mansoor W; McNamara MG; Hubner RA; Valle JW
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):723-731. PubMed ID: 29923433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.
    Domínguez-Muñoz JE; Nieto-Garcia L; López-Díaz J; Lariño-Noia J; Abdulkader I; Iglesias-Garcia J
    BMC Cancer; 2018 May; 18(1):534. PubMed ID: 29728096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.
    Roberts KJ; Bannister CA; Schrem H
    Pancreatology; 2019 Jan; 19(1):114-121. PubMed ID: 30385188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic Enzyme Replacement Therapy in Children with Severe Acute Malnutrition: A Randomized Controlled Trial.
    Bartels RH; Bourdon C; Potani I; Mhango B; van den Brink DA; Mponda JS; Muller Kobold AC; Bandsma RH; Boele van Hensbroek M; Voskuijl WP
    J Pediatr; 2017 Nov; 190():85-92.e2. PubMed ID: 28912050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exocrine pancreatic insufficiency following esophagectomy.
    Huddy JR; Macharg FM; Lawn AM; Preston SR
    Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management.
    Dunleavy L; Al-Mukhtar A; Halliday V
    Clin Nutr ESPEN; 2018 Aug; 26():97-103. PubMed ID: 29908691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.
    Barkin JA; Westermann A; Hoos W; Moravek C; Matrisian L; Wang H; Shemanski L; Barkin JS; Rahib L
    Pancreas; 2019 Jul; 48(6):780-786. PubMed ID: 31210656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency.
    Layer P; Kashirskaya N; Gubergrits N
    World J Gastroenterol; 2019 May; 25(20):2430-2441. PubMed ID: 31171887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States.
    Jain T; Sharma P; Giri B; Iyer S; Sethi V; Bava EP; Vaish U; Sahay P; Datta J; Reddy S; Bart Rose J; Khan A; Merchant N; Chari ST; Dudeja V
    HPB (Oxford); 2022 Oct; 24(10):1729-1737. PubMed ID: 35717430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent.
    Forsmark CE; Tang G; Xu H; Tuft M; Hughes SJ; Yadav D
    Aliment Pharmacol Ther; 2020 May; 51(10):958-967. PubMed ID: 32249970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic Enzyme Replacement Therapy in Patients with Non-pancreatic Digestive Conditions: A Nationwide Claims Analysis.
    Phillips AE; Tang G; Wang X; Forsmark CE; Yadav D
    Dig Dis Sci; 2023 May; 68(5):1754-1761. PubMed ID: 36370243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer.
    Roeyen G; Berrevoet F; Borbath I; Geboes K; Peeters M; Topal B; Van Cutsem E; Van Laethem JL
    ESMO Open; 2022 Feb; 7(1):100386. PubMed ID: 35124465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Use of Long-Acting Somatostatin Analogues (SSAs) and Exocrine Pancreatic Insufficiency (EPI) in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): An Under-recognized Adverse Effect.
    Saif MW; Romano A; Smith MH; Patel R; Relias V
    Cancer Med J; 2020; 3(2):75-84. PubMed ID: 32405630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pancreatic enzyme replacement therapy on short- and long-term outcomes in advanced pancreatic cancer: meta-analysis of randomized controlled trials.
    Ammar K; Leeds JS; Ratnayake CB; Sen G; French JJ; Nayar M; Oppong KW; Loveday BP; Pandanaboyana S
    Expert Rev Gastroenterol Hepatol; 2021 Aug; 15(8):941-948. PubMed ID: 33522321
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of pancreatic exocrine insufficiency after pancreatic surgery measured by
    Hartman V; Roeyen E; Bracke B; Huysentruyt F; De Gendt S; Chapelle T; Ysebaert D; Hendrikx B; Roeyen G
    Pancreatology; 2023 Aug; 23(5):563-568. PubMed ID: 37301695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-World Patient Experience With Pancreatic Enzyme Replacement Therapy in the Treatment of Exocrine Pancreatic Insufficiency.
    Barkin JA; Harb D; Kort J; Barkin JS
    Pancreas; 2024 Jan; 53(1):e16-e21. PubMed ID: 38039440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types.
    Lewis DM; Rieke JG; Almusaylim K; Kanchibhatla A; Blanchette JE; Lewis C
    Dig Dis Sci; 2024 Feb; 69(2):615-633. PubMed ID: 38117426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding pancreatic exocrine insufficiency and replacement therapy in pancreatic cancer.
    Powell-Brett S; de Liguori Carino N; Roberts K
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt A):539-544. PubMed ID: 32178962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.